ad image

Small-Cell Lung Cancer

1 / 1
Bristol-Myers Squibb
FDA Approval

U.S. Food and Drug Administration Approves Opdivo®(nivolumab) as the First New Medication in Nearly 20 Years for Certain Patients with Previously Treated Small Cell Lung Cancer

Bristol-Myers Squibb

PR-M09-18-NI-065Sep 21, 2018
Amgen
Collaboration

Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Cancer

Amgen

PR-M06-18-NI-028Jun 08, 2018
1 / 1